Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02088554 · ClinicalTrials.gov registry record · NA
PERIGON Pivotal Trial
A NA study of Aortic Stenosis, sponsored by Medtronic Cardiac Surgery.
- Active
- Registry status
- NA
- Development phase
- 1,312
- Enrollment target
- 20
- Study locations
NCT02088554 is a NA study of Aortic Stenosis that is active but no longer recruiting, run by Medtronic Cardiac Surgery. The registered enrollment target is 1,312 participants, roughly in line with the 1,312-participant average among 26 other Aortic Stenosis trials with a reported enrollment target. The trial reports 20 study locations across 15 states.
The verdict
NCT02088554, a NA study of Aortic Stenosis, is active but no longer recruiting, sponsored by Medtronic Cardiac Surgery.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,312 participants
- Enrollment target
- 20
- Study locations
Study Summary
To evaluate the safety and effectiveness of the Model 400 aortic valve bioprosthesis.
Conditions Studied
Interventions
- DEVICE Model 400 aortic valve bioprosthesis
Study Locations (20)
New York
- Maimonides Medical Center - Brooklyn
- The Mount Sinai Medical Center - New York
- New York-Presbyterian Hospital/Columbia University Medical Center - New York
Ohio
- Cleveland Clinic - Cleveland
- Riverside Methodist Hospital (OhioHealth) - Columbus
- ProMedica Toledo Hospital - Toledo
Texas
- Cardiothoracic and Vascular Surgeons (CTVS) - Austin
- Houston Methodist Hospital - Houston
California
- University of Southern California (USC) University Hospital - Los Angeles
Colorado
- University of Colorado Hospital - Aurora
Connecticut
- Hartford Hospital - Hartford
Florida
- University of Florida Shands - Gainesville
Georgia
- Piedmont Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,312 participants |
| Start Date | 2014-05-12 |
| Est. Completion | 2035-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02088554
The ClinicalTrials.gov registry entry for NCT02088554 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,312 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,312-participant average among 26 other Aortic Stenosis trials with a reported enrollment target. The listed sponsor is Medtronic Cardiac Surgery, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortic Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Model 400 aortic valve bioprosthesis is the first listed.
NCT02088554 reports 20 study locations spanning 15 distinct geographic areas - top geographies include New York, Ohio, Texas.
Frequently Asked Questions
What is clinical trial NCT02088554 about?
NCT02088554 is a clinical study titled "PERIGON Pivotal Trial". To evaluate the safety and effectiveness of the Model 400 aortic valve bioprosthesis.
What is the current status of trial NCT02088554?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,312 participants. The study started on 2014-05-12. Estimated completion is 2035-12-31.
What conditions does trial NCT02088554 study?
This clinical trial studies the following conditions: Aortic Stenosis.
What interventions are being tested in trial NCT02088554?
The interventions under investigation include: Model 400 aortic valve bioprosthesis (DEVICE).
Who is sponsoring clinical trial NCT02088554?
This trial is sponsored by Medtronic Cardiac Surgery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02088554 being conducted?
This trial has 20 study locations across California, Colorado, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
RECRUITING · NA
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
-
Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure
RECRUITING · NA
-
PARTNER 3 Trial - Aortic Valve-in-Valve
RECRUITING · NA
-
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
RECRUITING · NA
-
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.